Javascript must be enabled to continue!
P0077 Identification of symbiote candidates for pouchitis in patients with ulcerative colitis
View through CrossRef
Abstract
Background
Ulcerative colitis (UC) has been recognized as a life-long inflammatory disease. Although several novel treatments for UC has been developed, medication-uncontrollable UC patients require the surgical treatment. The surgical operation could improve the quality of life of the patients, but requires intensive medical following, because more than 40% develop to pouchitis. We have explored the symbiote candidates for Ileoanal pouch through comprehensive microbiome and metabolome analysis to prove the mechanism of pouchitis.
Methods
The fecal samples in patients with or without pouchitis were collected. 16S rRNA amplicon meta-analysis and metabolome analysis for 170 patients were performed.
Results
The alfa diversity in microbiome was significantly decreased with developing pouchitis. Several bacterial genera which include Lachnospiraceae, Bifidobacteriaceae, Prevotellaceae, Clostridiaceae, Ruminococcaceae, and Veillonellaceae were statistically reduced in correlation with inflammatory clinical score and were shown having significant relation with protective metabolites. In addition, the extent of decrease in these candidates was strikingly prominent in medication-refractory pouchitis. Additionally, some pouchitis revealed the increasing of Enterobacteriaceae, unclassified Lactobacillas, or Propionibacteriaceae.
Conclusion
Thus, our data show these bacterial taxa as symbiote candidates and could be attractive targets for maintenance of Ileal pouch in UC.
Oxford University Press (OUP)
Title: P0077 Identification of symbiote candidates for pouchitis in patients with ulcerative colitis
Description:
Abstract
Background
Ulcerative colitis (UC) has been recognized as a life-long inflammatory disease.
Although several novel treatments for UC has been developed, medication-uncontrollable UC patients require the surgical treatment.
The surgical operation could improve the quality of life of the patients, but requires intensive medical following, because more than 40% develop to pouchitis.
We have explored the symbiote candidates for Ileoanal pouch through comprehensive microbiome and metabolome analysis to prove the mechanism of pouchitis.
Methods
The fecal samples in patients with or without pouchitis were collected.
16S rRNA amplicon meta-analysis and metabolome analysis for 170 patients were performed.
Results
The alfa diversity in microbiome was significantly decreased with developing pouchitis.
Several bacterial genera which include Lachnospiraceae, Bifidobacteriaceae, Prevotellaceae, Clostridiaceae, Ruminococcaceae, and Veillonellaceae were statistically reduced in correlation with inflammatory clinical score and were shown having significant relation with protective metabolites.
In addition, the extent of decrease in these candidates was strikingly prominent in medication-refractory pouchitis.
Additionally, some pouchitis revealed the increasing of Enterobacteriaceae, unclassified Lactobacillas, or Propionibacteriaceae.
Conclusion
Thus, our data show these bacterial taxa as symbiote candidates and could be attractive targets for maintenance of Ileal pouch in UC.
Related Results
Pouchitis: extracolonic manifestation of ulcerative colitis?
Pouchitis: extracolonic manifestation of ulcerative colitis?
Pouchitis is the most frequent complication of ileal pouch-anal anastomosis for treatment of ulcerative colitis. There are several possible explanations. Among them, we focus on th...
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Vedolizumab levels are associated with clinical remission in pouchitis
Vedolizumab levels are associated with clinical remission in pouchitis
Abstract
Background
Pouchitis is the most common complication in ulcerative colitis (UC) patients following ileal pouch anal anastomosis (IPAA). Recent studies have demons...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
A Clinical Review on Ulcerative Colitis (Colon Cancer)
A Clinical Review on Ulcerative Colitis (Colon Cancer)
Ulcerative colitis (UC) is also known as colon cancer or colorectal cancer, a chronic inflammatory condition of the large intestine (colon and rectum). It comes under blood in stoo...
P033 Cytomegalovirus colitis: Does concomitant inflammatory bowel disease lead to worse clinical outcomes? Descriptive study from a single-centre experience
P033 Cytomegalovirus colitis: Does concomitant inflammatory bowel disease lead to worse clinical outcomes? Descriptive study from a single-centre experience
BACKGROUND:
The association between cytomegalovirus (CMV) colitis and inflammatory bowel diseases (IBD) is well documented. Current studies estimate a 2% risk of CMV re...
Pharmacological correction of ulcerative colitis with dalargin
Pharmacological correction of ulcerative colitis with dalargin
Introduction: Ulcerative colitis is a chronic colonic disease with frequent relapses, affecting mainly people of active age. The effectiveness of existing treatment methods remains...

